NEW HORIZ.HEAL. DL-00005
New Horizon Health Limited, an investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People's Republic of China. Its products include ColoClear, an early screening products for colon cancer; Pupu Tube, a fecal occult blood self test product; and UU Tube, a helicobacter pylori self-test products. The com… Read more
NEW HORIZ.HEAL. DL-00005 (6YZ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, NEW HORIZ.HEAL. DL-00005 (6YZ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NEW HORIZ.HEAL. DL-00005 - Net Assets Trend (None–None)
This chart illustrates how NEW HORIZ.HEAL. DL-00005's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NEW HORIZ.HEAL. DL-00005 (None–None)
The table below shows the annual net assets of NEW HORIZ.HEAL. DL-00005 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NEW HORIZ.HEAL. DL-00005's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NEW HORIZ.HEAL. DL-00005 Competitors by Market Cap
The table below lists competitors of NEW HORIZ.HEAL. DL-00005 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Silicon2 Co. Ltd.
KQ:257720
|
$552.95 Million |
|
Daishin Securities Co Ltd Pref 2
KO:003547
|
$552.98 Million |
|
SCG Packaging Public Company Limited
BK:SCGP
|
$553.20 Million |
|
Air New Zealand Limited
PINK:ANZFF
|
$553.25 Million |
|
Télévision Française 1 Société anonyme
PINK:TVFCF
|
$552.75 Million |
|
Lotus Retail Growth Freehold and Leasehold Property Fund
BK:LPF
|
$552.62 Million |
|
Browave
TWO:3163
|
$552.58 Million |
|
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION
|
$552.47 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NEW HORIZ.HEAL. DL-00005's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NEW HORIZ.HEAL. DL-00005's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NEW HORIZ.HEAL. DL-00005 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NEW HORIZ.HEAL. DL-00005's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NEW HORIZ.HEAL. DL-00005 (6YZ) | €- | N/A | N/A | $552.84 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |